Menu
x
Who We Are
Our Story
Leadership Team
What We Do
Our Services
New Facility
Partners
Collaborators / Partners
Clients
Investors
Careers
News & Events
Who We Are
Our Story
Leadership Team
What We Do
Our Services
New Facility
Partners
Collaborators / Partners
Clients
Investors
Careers
News & Events
Back to all news
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
Atomvie Blog
|
February 24, 2026
SHARE